Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
6 February 2023
|
|
m 18:08 | Colorectal cancer 5 changes history +1,797 [Jwarner (5×)] | |||
| m |
|
18:08 (cur | prev) +209 Jwarner talk contribs →Regorafenib monotherapy {{#subobject:b6f696|Regimen=1}} | |||
| m |
|
18:06 (cur | prev) +425 Jwarner talk contribs →FOLFIRINOX & Bevacizumab (L-Leucovorin) {{#subobject:9bf7|Regimen=1}} | |||
| m |
|
17:57 (cur | prev) +209 Jwarner talk contribs →FOLFOX4 & Bevacizumab {{#subobject:8228ca|Regimen=1}} | |||
| m |
|
17:56 (cur | prev) +209 Jwarner talk contribs →FOLFIRI & Ramucirumab {{#subobject:pyr1|Regimen=1}} | |||
| m |
|
14:53 (cur | prev) +745 Jwarner talk contribs | |||
|
|
18:00 | Colorectal cancer, RAS wild-type 8 changes history +11,854 [Jwarner (8×)] | |||
| m |
|
18:00 (cur | prev) +208 Jwarner talk contribs →Panitumumab monotherapy {{#subobject:5a3eb5|Regimen=1}} | |||
|
|
14:58 (cur | prev) +3,099 Jwarner talk contribs →FOLFIRI & Panitumumab {{#subobject:8c0093|Regimen=1}} | ||||
| m |
|
14:46 (cur | prev) +209 Jwarner talk contribs →Cetuximab monotherapy {{#subobject:a41ec2|Regimen=1}} | |||
| m |
|
14:46 (cur | prev) +60 Jwarner talk contribs →Regimen {{#subobject:fa978e|Variant=1}} | |||
|
|
14:28 (cur | prev) +4,523 Jwarner talk contribs →Advanced or metastatic disease, first-line | ||||
| m |
|
12:05 (cur | prev) +1,901 Jwarner talk contribs →mFOLFOX6 & Panitumumab {{#subobject:avn786|Regimen=1}} | |||
| m |
|
12:00 (cur | prev) +1,513 Jwarner talk contribs →mFOLFOX6-B {{#subobject:8ugz86|Regimen=1}} | |||
| m |
|
11:52 (cur | prev) +341 Jwarner talk contribs →FOLFOX4 & Panitumumab {{#subobject:486271|Regimen=1}} | |||
|
|
m 11:44 | Breast cancer 2 changes history +700 [Jwarner (2×)] | |||
| m |
|
11:44 (cur | prev) +384 Jwarner talk contribs →Regimen variant #2 {{#subobject:25ef0|Variant=1}} | |||
| m |
|
01:16 (cur | prev) +316 Jwarner talk contribs →Paclitaxel & Bevacizumab {{#subobject:ab5252|Regimen=1}} | |||
|
|
m 01:19 | Breast cancer, ER-positive 2 changes history +854 [Jwarner (2×)] | |||
| m |
|
01:19 (cur | prev) +447 Jwarner talk contribs →Everolimus & Exemestane {{#subobject:c6aadc|Regimen=1}} | |||
| m |
|
01:03 (cur | prev) +407 Jwarner talk contribs →Letrozole & Ribociclib {{#subobject:b27d88|Regimen=1}} | |||
| m 01:09 | Breast cancer, HER2-positive diffhist +554 Jwarner talk contribs →Capecitabine & Lapatinib {{#subobject:5474dd|Regimen=1}} | ||||
5 February 2023
| N 16:48 | Category:Tumor infiltrating lymphocytes diffhist +34 Jwarner talk contribs Created page with "Category:Immune effector cells" | ||||
| N 16:47 | Category:Melanoma medications (investigational) diffhist +33 Jwarner talk contribs Created page with "Category:Melanoma medications" | ||||
| N 16:47 | Lifileuecel (Contego) diffhist +942 Jwarner talk contribs Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifileucel NCI Drug Dictionary]: A preparation of autologous tumor infiltrat..." | ||||
| m 16:45 | Melanoma diffhist +23 Jwarner talk contribs →TILs {{#subobject:f33e1b|Regimen=1}} | ||||
|
|
m 13:17 | Breast cancer, ER-positive 2 changes history +2,870 [Jwarner (2×)] | |||
| m |
|
13:17 (cur | prev) +1,279 Jwarner talk contribs | |||
| m |
|
13:11 (cur | prev) +1,591 Jwarner talk contribs | |||
|
|
m 02:59 | Breast cancer, HER2-positive 8 changes history +5,238 [Jwarner (8×)] | |||
| m |
|
02:59 (cur | prev) +428 Jwarner talk contribs →Lapatinib & Trastuzumab {{#subobject:9be4d2|Regimen=1}} | |||
| m |
|
02:53 (cur | prev) +207 Jwarner talk contribs →THP (Docetaxel) {{#subobject:938b69|Regimen=1}} | |||
| m |
|
02:51 (cur | prev) +2,846 Jwarner talk contribs | |||
| m |
|
02:47 (cur | prev) +1,231 Jwarner talk contribs | |||
| m |
|
02:43 (cur | prev) +168 Jwarner talk contribs →THP (Docetaxel) {{#subobject:24b376|Regimen=1}} | |||
| m |
|
02:41 (cur | prev) +4 Jwarner talk contribs →Regimen variant #5, 1-year total course, q3wk {{#subobject:857980|Variant=1}} | |||
| m |
|
01:09 (cur | prev) +150 Jwarner talk contribs →Regimen variant #5, 1-year total course, q3wk {{#subobject:857980|Variant=1}} | |||
| m |
|
01:05 (cur | prev) +204 Jwarner talk contribs →Regimen variant #5, 1-year total course, q3wk {{#subobject:857980|Variant=1}} | |||
4 February 2023
|
|
m 21:53 | Sacituzumab govitecan (Trodelvy) 4 changes history +486 [Jwarner (4×)] | |||
| m |
|
21:53 (cur | prev) +49 Jwarner talk contribs →History of changes in FDA indication | |||
| m |
|
21:53 (cur | prev) +32 Jwarner talk contribs | |||
| m |
|
21:52 (cur | prev) +7 Jwarner talk contribs →Diseases for which it is used | |||
| m |
|
21:52 (cur | prev) +398 Jwarner talk contribs | |||
| m 21:35 | Gallbladder cancer diffhist +180 Jwarner talk contribs →ESMO | ||||
| m 21:34 | Cholangiocarcinoma diffhist +180 Jwarner talk contribs →ESMO | ||||
|
|
m 18:58 | Chronic lymphocytic leukemia 5 changes history +2,293 [Jwarner (5×)] | |||
| m |
|
18:58 (cur | prev) +1,654 Jwarner talk contribs →Ibrutinib & Venetoclax {{#subobject:7c8bdd|Regimen=1}} | |||
| m |
|
18:50 (cur | prev) -12 Jwarner talk contribs | |||
| m |
|
18:48 (cur | prev) +1,907 Jwarner talk contribs →Ibrutinib & Rituximab {{#subobject:7ccq6f|Regimen=1}} | |||
| m |
|
18:48 (cur | prev) -1,906 Jwarner talk contribs →Ibrutinib & Venetoclax {{#subobject:7c8bdd|Regimen=1}} | |||
| m |
|
18:47 (cur | prev) +650 Jwarner talk contribs →Chlorambucil & Obinutuzumab (GClb) {{#subobject:50878e|Regimen=1}} | |||
|
|
m 18:39 | Hepatocellular carcinoma 7 changes history +144 [Jwarner (7×)] | |||
| m |
|
18:39 (cur | prev) +122 Jwarner talk contribs →Durvalumab & Tremelimumab {{#subobject:87gaf8|Regimen=1}} | |||
| m |
|
18:38 (cur | prev) +3,822 Jwarner talk contribs →Local therapy | |||
| m |
|
18:38 (cur | prev) -3,800 Jwarner talk contribs →Adjuvant therapy | |||
| m |
|
18:37 (cur | prev) +1,853 Jwarner talk contribs →TACE monotherapy {{#subobject:f96a1b|Regimen=1}} | |||
| m |
|
18:37 (cur | prev) -1,853 Jwarner talk contribs →TACE, then 5-FU {{#subobject:572d2d|Regimen=1}} | |||
| m |
|
18:37 (cur | prev) +2,555 Jwarner talk contribs →FOLFOX-HAIC {{#subobject:jiuga2|Variant=1}} | |||
| m |
|
18:37 (cur | prev) -2,555 Jwarner talk contribs →FOFLFOX-HAIC & Sorafenib {{#subobject:jix4b2|Variant=1}} | |||